AZELASIGN 10 Cream is a pharmaceutical-grade topical preparation that contains 10% Azelaic Acid, a naturally occurring dicarboxylic acid derived from grains like barley, wheat, and rye. It is widely used in dermatology for the treatment of acne vulgaris and rosacea due to its unique combination of antibacterial, anti-inflammatory, and keratolytic properties. The cream is formulated to deliver therapeutic concentrations of Azelaic Acid directly to the epidermis, promoting clear skin while maintaining a high level of safety and tolerability.
AZELASIGN 10 Cream works by targeting several key pathogenic factors involved in acne formation. It inhibits the growth of Propionibacterium acnes, the bacteria responsible for acne breakouts, and reduces the production of keratin, thereby preventing the clogging of pores. Additionally, Azelaic Acid reduces the formation of comedones, papules, and pustules through its anti-inflammatory action, making it effective in managing both inflammatory and non-inflammatory acne lesions. For individuals suffering from rosacea, the cream helps in decreasing redness, swelling, and the appearance of visible blood vessels (telangiectasia) on the face.
One of the most valuable attributes of AZELASIGN 10 Cream is its favorable tolerability profile compared to other topical agents like benzoyl peroxide or retinoids. It is non-comedogenic, alcohol-free, and does not bleach hair or clothing, making it suitable for sensitive skin types and individuals prone to irritation. Its mild formulation also allows for long-term use without the risk of bacterial resistance, which is a growing concern with topical and oral antibiotics.
Upon application, Azelaic Acid penetrates the follicular epithelium and exerts its effects at the cellular level. It inhibits mitochondrial oxidoreductase and 5-alpha-reductase enzymes, reducing the production of reactive oxygen species and sebum, thereby supporting overall skin normalization. It also possesses anti-tyrosinase activity, helping in the reduction of hyperpigmentation associated with post-inflammatory acne scarring or melasma. As such, AZELASIGN 10 Cream is not only a treatment for active acne but also contributes to improving skin tone, texture, and pigmentation over time.
The cream is typically applied twice daily to the affected areas after gentle cleansing. Visible improvement is often observed within 4 weeks, although full therapeutic benefits may require up to 12 weeks of consistent use. It is advisable to use sunscreen during the day while on Azelaic Acid therapy to prevent photo-sensitization and pigmentation issues, especially in individuals with darker skin tones.
From a pharmaceutical manufacturing perspective, AZELASIGN 10 Cream is developed using high-purity active ingredients and dermatologically tested excipients that ensure optimal skin absorption and stability. The cream base is smooth, non-greasy, and designed to be rapidly absorbed without leaving a residue. It is available in aluminum tubes or airless pump containers to maintain product integrity and prevent oxidation.
BluepillExpress, as a third-party manufacturer, ensures that AZELASIGN 10 Cream is produced in WHO-GMP and ISO-certified facilities, using validated manufacturing processes and stringent quality control checks. Each batch undergoes microbial limit testing, assay verification, pH consistency checks, and preservative efficacy tests to meet international regulatory and safety standards. The product can be customized for private labeling, export packaging, and market-specific branding as per the client's regulatory requirements.
AZELASIGN 10 Cream is also a preferred option for dermatologists and aesthetic practitioners as an adjunct to chemical peels, laser treatments, and other cosmetic dermatological procedures. It supports post-procedure recovery by reducing inflammation and the risk of post-inflammatory hyperpigmentation. Furthermore, it can be safely co-prescribed with oral antibiotics or isotretinoin, as part of a multimodal acne treatment strategy.
As the global demand for safe, effective, and resistance-free acne therapies grows, AZELASIGN 10 Cream stands out as a reliable, evidence-based product with broad therapeutic appeal. It is particularly suitable for export to markets where demand for non-antibiotic dermatological treatments is rising, including the United States, Europe, Southeast Asia, and the Middle East. With comprehensive dossier support, stability data, and adaptable packaging options, BluepillExpress offers full-service third-party manufacturing solutions for AZELASIGN 10 Cream across regulated and semi-regulated markets.
In conclusion, AZELASIGN 10 Cream is a scientifically formulated Azelaic Acid 10% topical treatment that provides effective management of acne and rosacea, while also enhancing skin clarity and texture. Its non-irritating formulation, multifaceted therapeutic action, and long-standing clinical support make it a valuable addition to any dermatological product portfolio. Whether for prescription-based therapy or over-the-counter skin solutions, AZELASIGN 10 Cream is an ideal product for healthcare providers, distributors, and skincare brands seeking high-quality, trusted acne treatment options.
Description provided by bluepill express.
FIEO Registered
Export Ready
